TradeLink Capital’s Haemonetics HAE Stock Holding History

TradeLink Capital’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,969	Closed	-$1.04M	–	45
2025 Q2	$1.04M	Buy	13,969 +5,128	+58%	+$340K	3.69%	7
2025 Q1	$571K	Sell	8,841 -2,716	-24%	-$185K	3.53%	9
2024 Q4	$902K	Buy	+11,557	New	+$928K	8.9%	4
2024 Q3	–	Sell	-4,829	Closed	-$400K	–	37
2024 Q2	$400K	Buy	+4,829	New	+$425K	1.15%	33
2019 Q3	–	Sell	-1,700	Closed	-$205K	–	28
2019 Q2	$205K	Buy	+1,700	New	+$167K	3.06%	9

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TradeLink Capital's HAE Position: Q3 2025 in Review

TradeLink Capital sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 13,969 shares — an estimated $1.04M sold.

TradeLink Capital first reported a position in HAE in Q2 2019 and held it in 5 quarters. The position peaked at $1.04M in Q2 2025. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

TradeLink Capital reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
TradeLink Capital sold 13,969 Haemonetics shares in Q3 2025, an estimated $1.04M.
TradeLink Capital first reported a position in Haemonetics in Q2 2019 and held it in 5 quarters.
TradeLink Capital's Haemonetics position peaked at $1.04M in Q2 2025.
301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on TradeLink Capital's 13F filing for Q3 2025, filed 3 Nov 2025.